Average Co-Inventor Count = 10.33
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (15 from 116 patents)
2. Abbvie Inc. (12 from 822 patents)
3. Abbott Laboratories Corporation (10 from 4,179 patents)
4. Abbvie S.a.r.l. (10 from 15 patents)
5. Abbvie Overseas Sarl (5 from 5 patents)
37 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
7. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
8. 10399940 - Substituted pyrrolidines and methods of use
9. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
10. 10130622 - Compounds for treatment of cystic fibrosis
11. 10047051 - Substituted pyridines and method of use
12. 9983218 - Indole and indoline derivatives and methods of use thereof
13. 9981910 - Substituted pyrrolidines and methods of use
14. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
15. 9840513 - Substituted tricyclics and method of use